Edarbi and Gabapentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Edarbi (azilsartan medoxomil) and Gabapentin (gabapentin). Common drug interactions include blood creatinine increased among females and pain of skin among males.

The phase IV clinical study analyzes what interactions people have when they take Edarbi and Gabapentin. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Edarbi?

Edarbi has active ingredients of azilsartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 404 Edarbi users. Check the latest studies of Edarbi.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.

On Jul, 16, 2026

16 people who take Edarbi and Gabapentin together, and have interactions are studied.

Edarbi and Gabapentin drug interactions.

What are the common drug interactions of Edarbi and Gabapentin, by gender? *:

female:

Blood creatinine increased
Blood potassium increased
Glomerular filtration rate decreased
Squamous cell carcinoma (a cancer of a kind of epithelial cell)
Vitamin b1 increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Abasia (inability to walk)
Activities of daily living impaired
Burning sensation
Death

male:

Pain of skin
Subdural haematoma (blood collects between the skull and the surface of the brain)
Dyslipidaemia (abnormal amount of lipids)
Gout (uric acid crystals building up in the body)
Hypokalaemia (low potassium)
Intermittent claudication
Renal impairment (severely reduced kidney function)
Staphylococcal infection (an infection with staphylococcus bacteria)
Electrocardiogram t wave inversion
Fatigue (feeling of tiredness)

What are the common drug interactions of Edarbi and Gabapentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blood creatinine increased
Blood potassium increased
Glomerular filtration rate decreased
Vitamin b1 increased

50-59:

Dehydration (dryness resulting from the removal of water)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Dyslipidaemia (abnormal amount of lipids)
Gout (uric acid crystals building up in the body)
Hypokalaemia (low potassium)
Intermittent claudication
Renal impairment (severely reduced kidney function)
Staphylococcal infection (an infection with staphylococcus bacteria)
Electrocardiogram t wave inversion
Fatigue (feeling of tiredness)

60+:

Pain of skin
Subdural haematoma (blood collects between the skull and the surface of the brain)
Squamous cell carcinoma (a cancer of a kind of epithelial cell)

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 18.75%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 18.75%
Headache (pain in head): 3 people, 18.75%
Type 2 Diabetes: 2 people, 12.50%
Itching: 2 people, 12.50%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 12.50%
Gastric Ulcer (stomach ulcer): 2 people, 12.50%
Irritable Bowel Syndrome: 2 people, 12.50%
Pain: 1 person, 6.25%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Edarbi and Gabapentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously